JA-PASS and JA-CASS cutoff values for parent-reported, child-reported, and physician-reported outcome measures and acute-phase reactant levels at baseline, second, and third visit in children who were reported as being in JA-PASS by their parents in 3 consecutive visits or reported themselves as being in JA-CASS in 2 consecutive visits (75% percentile approach).
| Variable and Range | JA-PASS, n = 171 | JA-CASS, n = 85 | |||
|---|---|---|---|---|---|
| First Visit | Second Visit | Third Visit | First Visit | Second Visit | |
| Parent/child well-being VAS score, 0–10 | 2 | 2 | 1.5 | 1.2 | 1 |
| Parent/child pain VAS score, 0–10 | 1.5 | 1 | 1 | 1 | 1 |
| Parent/child disease activity VAS score, 0–10 | 2 | 1.5 | 1 | 1 | 1 |
| Parent/child JAFS total score, 0–30 | 1 | 0 | 0 | 1 | 1 |
| Parent/child PRQL total score, 0–30 | 4 | 3 | 3 | 3 | 3 |
| Parent/child PRQL-PhH score, 0–15 | 2.5 | 2 | 2 | 2 | 1 |
| Parent/child PRQL-PsH score, 0–15 | 2 | 2 | 2 | 2 | 1 |
| Physician global assessment VAS, 0–10 | 1.1 | 1.5 | 1 | 1 | 1 |
| No. active joints, 0–73 | 1 | 2 | 1 | 1 | 1 |
| No. swollen joints, 0–68 | 1 | 1 | 1 | 1 | 1 |
| No. tender joints, 0–73 | 1 | 1 | 1 | 2 | 2 |
| No. restricted joints, 0–71 | 1 | 2 | 1 | 1 | 1 |
| ESR, mm/h, 20–140 | 22 | 19 | 23 | 21 | 19 |
| CRP, mg/dl, < 0.46–infinity* | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
↵* All values below 0.46 mg/dl were converted to 0.3 mg/dl. JA-PASS: parent acceptable symptom state in juvenile arthritis; JA-CASS: child acceptable symptom state in juvenile arthritis; VAS: visual analog scale; JAFS: Juvenile Arthritis Functionality Scale; PRQL: Paediatric Rheumatology Quality of Life Scale; PhH: physical health; PsH: psychosocial health; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein.